Press Releases

CRT spins out company to develop cancer surgery machine to melt tumours - January 26 2012
CRT appoints new Chairman to its Board of Directors - October 13 2011
CRT and Cancer Research UK establish Lipid Metabolism Research Team - September 29 2011
MISSION Therapeutics, a new spin-out, secures £6M in Series-A funding led by Sofinnova Partners - August 25 2011
CRT and Kurma Biofund to develop new antibody platform for translational research - June 13 2011
CDP signs deal with Centella Therapeutics, Inc. to launch development of radiotherapy-enhancing drug - May 25 2011
Cancer Research Technology and Affitech A/S sign exclusive antibody development deal - April 27 2011
Senectus Therapeutics and AstraZeneca collaborate to identify triggers to cell ageing - March 23 2011
Cancer Research Technology, The ICR and ZoBio BV sign deal to develop cancer drugs - March 10 2011
Agreement reached to identify a predictive biomarker for PARP inhibitor therapies - February 02 2011
Cancer Research Technology and Cancer Research UK establish team of stem cell experts to beat cancer - January 14 2011
Cancer Research UK and AstraZeneca collaborate to trial combinations of new cancer drugs - January 13 2011
Cancer Research UK and immatics biotechnologies launch trial for brain cancer vaccine - October 19 2010
Cancer Research UK and AstraZeneca sign deal to trial first-of-kind cancer drug - September 13 2010
CRT & Bayer Schering investigate new therapeutic approach in gynaecological & oncological diseases - August 25 2010
CRT and ValiRx sign licensing deal to develop Prostate Cancer treatment - August 12 2010
Antibody Licence Agreement with Scancell Holdings Plc - August 09 2010
“Skills Swap” to exploit expertise for patient benefit - July 07 2010
UK-NZ collaboration to home in on new anti-cancer drug for leukaemia - April 22 2010
CRT announces partnership with Cephalon to develop a new class of anti-cancer drugs - March 19 2010

‹ Older Articles

ARCHIVES

© Cancer Research Technology 2012